INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Insmed Incorporated & Rem...
20 Juillet 2016 - 5:09PM
Business Wire
Khang & Khang LLP (the “Firm”) announces that a class action
lawsuit has been filed against Insmed Incorporated (“Insmed” or the
“Company”) (Nasdaq: INSM). Investors who purchased or otherwise
acquired shares between March 18, 2013 and June 8, 2016 inclusive
(the “Class Period”), are encouraged to contact the Firm prior to
the September 13, 2016 lead plaintiff motion deadline.
If you purchased shares of Insmed during the Class Period,
please contact Joon M. Khang, Esquire, of Khang & Khang, 18101
Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949)
419-3834, or by e-mail at joon@khanglaw.com.
There has been no class certification in this case. Until
certification occurs, you are not represented by an attorney. You
may choose to take no action and remain a passive class member.
According to the Complaint, Insmed made false and/or misleading
statements and/or failed to disclose that: the data on which
Insmed’s European marketing authorization application relied on for
its lead product candidate for the treatment of NTM lung disease,
Arikayce, was not likely to support approval by the European
Medicines Agency (“EMA”); Arikayce’s approval by the EMA for the
treatment of NTM lung disease and subsequent commercialization in
Europe were thus less likely than the Company had led investors to
believe; and as a result of the above, Insmed’s public statements
were materially false and misleading at all relevant times.
If you wish to learn more about this lawsuit, or if
you have any questions concerning this notice or your rights,
please contact Joon M. Khang, a prominent litigator for almost two
decades, by telephone: (949) 419-3834, or by e-mail at
joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160720005922/en/
Khang & Khang LLPJoon M. Khang, Esq.Telephone:
949-419-3834Facsimile: 949-225-4474joon@khanglaw.com
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024